{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:44:20Z","timestamp":1770749060033,"version":"3.50.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,10]]},"DOI":"10.7759\/cureus.103329","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:09:51Z","timestamp":1770710991000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the Safety of Proton Pump Inhibitors and Histamine Type 2-Receptor Antagonists in the Prevention of Gastrointestinal Complications"],"prefix":"10.7759","author":[{"given":"Angelika","family":"Samborska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Karczewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Lichwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Szukalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Wr\u00f3blewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukasz","family":"Siwek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Balajewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-5005-8","article-title":"Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials","volume":"44","author":"Alhazzani W","year":"2018","unstructured":"Alhazzani W, Alshamsi F, Belley-Cote E, et al.. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med. 2018, 44:1-11. 10.1007\/s00134-017-5005-8","journal-title":"Intensive Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008687.pub2","article-title":"Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units","volume":"6","author":"Toews I","year":"2018","unstructured":"Toews I, George AT, Peter JV, Kirubakaran R, Fontes LE, Ezekiel JP, Meerpohl JJ. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units. Cochrane Database Syst Rev. 2018, 6:CD008687. 10.1002\/14651858.CD008687.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-020-00473-0","article-title":"Histamine-2 receptor antagonists versus proton pump inhibitors for septic shock after lower gastrointestinal tract perforation: a retrospective cohort study using a national inpatient database","volume":"8","author":"Suzuki J","year":"2020","unstructured":"Suzuki J, Sasabuchi Y, Hatakeyama S, et al.. Histamine-2 receptor antagonists versus proton pump inhibitors for septic shock after lower gastrointestinal tract perforation: a retrospective cohort study using a national inpatient database. J Intensive Care. 2020, 8:56. 10.1186\/s40560-020-00473-0","journal-title":"J Intensive Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4266\/acc.2021.00249","article-title":"Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis in critically ill patients","volume":"36","author":"Song MJ","year":"2021","unstructured":"Song MJ, Kim S, Boo D, et al.. Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis in critically ill patients. Acute Crit Care. 2021, 36:208-216. 10.4266\/acc.2021.00249","journal-title":"Acute Crit Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001562","article-title":"Proton pump inhibitors versus histamine-2-receptor antagonists for stress ulcer prophylaxis in critically ill patients: a meta-analysis and trial sequential analysis","volume":"56","author":"Deliwala SS","year":"2022","unstructured":"Deliwala SS, Hamid K, Goyal H, et al.. Proton pump inhibitors versus histamine-2-receptor antagonists for stress ulcer prophylaxis in critically ill patients: a meta-analysis and trial sequential analysis. J Clin Gastroenterol. 2022, 56:204-217. 10.1097\/MCG.0000000000001562","journal-title":"J Clin Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22190","article-title":"Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation: the PEPTIC randomized clinical trial","volume":"323","author":"Young PJ","year":"2020","unstructured":"Young PJ, Bagshaw SM, Forbes AB, et al.. Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation: the PEPTIC randomized clinical trial. JAMA. 2020, 323:616-626. 10.1001\/jama.2019.22190","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5009\/gnl16568","article-title":"Comparison of the hospital-acquired Clostridium difficile infection risk of using proton pump inhibitors versus histamine-2 receptor antagonists for prophylaxis and treatment of stress ulcers: a systematic review and meta-analysis","volume":"11","author":"Azab M","year":"2017","unstructured":"Azab M, Doo L, Doo DH, et al.. Comparison of the hospital-acquired Clostridium difficile infection risk of using proton pump inhibitors versus histamine-2 receptor antagonists for prophylaxis and treatment of stress ulcers: a systematic review and meta-analysis. Gut Liver. 2017, 11:781-788. 10.5009\/gnl16568","journal-title":"Gut Liver"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14983","article-title":"Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: a 15-year hospital cohort study using a common data model","volume":"35","author":"Seo SI","year":"2020","unstructured":"Seo SI, You SC, Park CH, et al.. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: a 15-year hospital cohort study using a common data model. J Gastroenterol Hepatol. 2020, 35:1325-1330. 10.1111\/jgh.14983","journal-title":"J Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000006330","article-title":"Society of Critical Care Medicine and American Society of Health-System Pharmacists guideline for the prevention of stress-related gastrointestinal bleeding in critically ill adults","volume":"52","author":"MacLaren R","year":"2024","unstructured":"MacLaren R, Dionne JC, Granholm A, et al.. Society of Critical Care Medicine and American Society of Health-System Pharmacists guideline for the prevention of stress-related gastrointestinal bleeding in critically ill adults. Crit Care Med. 2024, 52:e421-e430. 10.1097\/CCM.0000000000006330","journal-title":"Crit Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2020.06.022","article-title":"Hyperammonemic encephalopathy exacerbated by parenteral nutrition in fibrolamellar hepatocellular carcinoma","volume":"133","author":"Shah PA","year":"2020","unstructured":"Shah PA, Cho J, Albitar HA, Pajot G, Liu M, Ravi K. Hyperammonemic encephalopathy exacerbated by parenteral nutrition in fibrolamellar hepatocellular carcinoma. Am J Med. 2020, 133:e745-e746. 10.1016\/j.amjmed.2020.06.022","journal-title":"Am J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131558","article-title":"PPI versus histamine H2 receptor antagonists for prevention of upper gastrointestinal injury associated with low-dose aspirin: systematic review and meta-analysis","volume":"10","author":"Mo C","year":"2015","unstructured":"Mo C, Sun G, Wang YZ, Lu ML, Yang YS. PPI versus histamine H2 receptor antagonists for prevention of upper gastrointestinal injury associated with low-dose aspirin: systematic review and meta-analysis. PLoS One. 2015, 10:e0131558. 10.1371\/journal.pone.0131558","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000489165","article-title":"H2 receptor antagonists versus proton pump inhibitors in patients on dual antiplatelet therapy for coronary artery disease: a systematic review","volume":"140","author":"Almufleh A","year":"2018","unstructured":"Almufleh A, Ramirez FD, So D, Le May M, Chong AY, Torabi N, Hibbert B. H2 receptor antagonists versus proton pump inhibitors in patients on dual antiplatelet therapy for coronary artery disease: a systematic review. Cardiology. 2018, 140:115-123. 10.1159\/000489165","journal-title":"Cardiology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2562341","article-title":"Proton pump inhibitors are not associated with an increased risk of Clostridioides difficile infection: a systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Floria DE","year":"2025","unstructured":"Floria DE, Obeidat M, V\u00e1ncsa S, et al.. Proton pump inhibitors are not associated with an increased risk of Clostridioides difficile infection: a systematic review and meta-analysis of randomized controlled trials. Gut Microbes. 2025, 17:2562341. 10.1080\/19490976.2025.2562341","journal-title":"Gut Microbes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106488","article-title":"Proton pump inhibitors and the risk of Clostridioides difficile infection: a systematic review and dose-response meta-analysis","volume":"90","author":"Finke M","year":"2025","unstructured":"Finke M, Boven A, Vlieghe E, Engstrand L, Orsini N, Brusselaers N. Proton pump inhibitors and the risk of Clostridioides difficile infection: a systematic review and dose-response meta-analysis. J Infect. 2025, 90:106488. 10.1016\/j.jinf.2025.106488","journal-title":"J Infect"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.09.063","article-title":"Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions","volume":"138","author":"Ng FH","year":"2010","unstructured":"Ng FH, Wong SY, Lam KF, et al.. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. Gastroenterology. 2010, 138:82-88. 10.1053\/j.gastro.2009.09.063","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.09.006","article-title":"Similar efficacy of proton-pump inhibitors vs H2-receptor antagonists in reducing risk of upper gastrointestinal bleeding or ulcers in high-risk users of low-dose aspirin","volume":"152","author":"Chan FK","year":"2017","unstructured":"Chan FK, Kyaw M, Tanigawa T, et al.. Similar efficacy of proton-pump inhibitors vs H2-receptor antagonists in reducing risk of upper gastrointestinal bleeding or ulcers in high-risk users of low-dose aspirin. Gastroenterology. 2017, 152:105-110.e1. 10.1053\/j.gastro.2016.09.006","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/JCMA.0000000000000465","article-title":"Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: a randomized controlled trial","volume":"84","author":"Tseng ZF","year":"2021","unstructured":"Tseng ZF, Hsu PI, Peng NJ, et al.. Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: a randomized controlled trial. J Chin Med Assoc. 2021, 84:19-24. 10.1097\/JCMA.0000000000000465","journal-title":"J Chin Med Assoc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.385","article-title":"Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction","volume":"107","author":"Ng FH","year":"2012","unstructured":"Ng FH, Tunggal P, Chu WM, et al.. Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction. Am J Gastroenterol. 2012, 107:389-396. 10.1038\/ajg.2011.385","journal-title":"Am J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00640.x","article-title":"Hereditary colon cancers can be tiny: a cautionary case report of the results of colonoscopic surveillance","volume":"93","author":"Church J","year":"1998","unstructured":"Church J. Hereditary colon cancers can be tiny: a cautionary case report of the results of colonoscopic surveillance. Am J Gastroenterol. 1998, 93:2289-2290. 10.1111\/j.1572-0241.1998.00640.x","journal-title":"Am J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00331-6","article-title":"Progress in prophylaxis against NSAID-associated ulcers","volume":"104","author":"Hawkey CJ","year":"1998","unstructured":"Hawkey CJ. Progress in prophylaxis against NSAID-associated ulcers. Am J Med. 1998, 104:67-74. 10.1016\/S0002-9343(97)00331-6","journal-title":"Am J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2024.09.016","article-title":"Hospitalized patients on proton pump inhibitors for stress ulcer prophylaxis have a higher risk of Clostridioides difficile infection compared with those on histamine-2 receptor antagonists","volume":"154","author":"Wu LH","year":"2024","unstructured":"Wu LH, Wang JL, Liu YH, Su CC, Yang YK, Lin SJ, Cheng CL. Hospitalized patients on proton pump inhibitors for stress ulcer prophylaxis have a higher risk of Clostridioides difficile infection compared with those on histamine-2 receptor antagonists. J Hosp Infect. 2024, 154:9-17. 10.1016\/j.jhin.2024.09.016","journal-title":"J Hosp Infect"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2979","article-title":"Use of proton pump inhibitors and H2 blockers and risk of pneumonia","volume":"138","author":"Dublin S","year":"2010","unstructured":"Dublin S, Walker RL, Jackson ML, et al.. Use of proton pump inhibitors and H2 blockers and risk of pneumonia. Chest. 2010, 138:79-86. 10.1378\/chest.09-2979","journal-title":"Chest"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al.. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017, 358:j4008. 10.1136\/bmj.j4008","journal-title":"BMJ"},{"key":"ref25","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JPT","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche, et al.. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011, 343:d5928.","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4725-5","article-title":"Associations of proton-pump inhibitors and H2 receptor antagonists with chronic kidney disease: a meta-analysis","volume":"62","author":"Wijarnpreecha K","year":"2017","unstructured":"Wijarnpreecha K, Thongprayoon C, Chesdachai S, Panjawatanana P, Ungprasert P, Cheungpasitporn W. Associations of proton-pump inhibitors and H2 receptor antagonists with chronic kidney disease: a meta-analysis. Dig Dis Sci. 2017, 62:2821-2827. 10.1007\/s10620-017-4725-5","journal-title":"Dig Dis Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.94973.3","article-title":"Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID- 19: evidence from a large population-based cohort study","volume":"13","author":"Zeng R","year":"2024","unstructured":"Zeng R, Ma Y, Zhang L, et al.. Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID- 19: evidence from a large population-based cohort study. eLife. 2024, 13:94973. 10.7554\/eLife.94973.3","journal-title":"eLife"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450976-comparison-of-the-safety-of-proton-pump-inhibitors-and-histamine-type-2-receptor-antagonists-in-the-prevention-of-gastrointestinal-complications","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:09:52Z","timestamp":1770710992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450976-comparison-of-the-safety-of-proton-pump-inhibitors-and-histamine-type-2-receptor-antagonists-in-the-prevention-of-gastrointestinal-complications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.103329","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}